Company / Operating Margin
CRESCENT BIOPHARMA, INC. Operating Margin History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1407.5%
FY2025
5-year range
-1407.5% / 23.8%
FY2021-FY2025
Trend
-2109.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -2110% YoY in FY2025, a notable deviation from the 4-year average annual change of -810%.
Based on SEC 10-K filings.
-1407.5% in FY2025 with a 10-year CAGR of -1141.9%.
Declined from -74.1% to -1407.5% over the past 9 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -1141.9pp
Key checks
Key Insights
- In FY2025, operating margin decreased 2109.6% year-over-year.
- Peak operating margin was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1407.5% | -2109.6% |
| FY2017 | -63.7% | +14.1% |
| FY2016 | -74.1% | +72.1% |
| FY2015 | -265.6% | -1215.2% |
| FY2014 | 23.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026